FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop. - Test2 - elhamkhani - TriplyDB

FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.

FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.

http://www.wikidata.org/entity/Q37644850

about

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.

P2860

Q41291620-4851E5B0-08B1-41C8-93BE-8B6802F8C649

P2860

FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.

http://www.wikidata.org/entity/Q37644850

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

FOXM1 confers resistance to ge ...... endent positive feedback loop.

@en

FOXM1 confers resistance to ge ...... endent positive feedback loop.

@nl

type

label

FOXM1 confers resistance to ge ...... endent positive feedback loop.

@en

FOXM1 confers resistance to ge ...... endent positive feedback loop.

@nl

prefLabel

FOXM1 confers resistance to ge ...... endent positive feedback loop.

@en

FOXM1 confers resistance to ge ...... endent positive feedback loop.

@nl

P1433

Q37644850-D3E3BB4D-E508-4C68-B0E1-03963DCACE00

P1476

Q37644850-7A8C938B-076C-4A5A-A1E5-AF3130B5DDEB

P2093

Q37644850-4582429D-7CE3-4954-A920-C0CE1B3D254F

Q37644850-61E72478-D5D8-4191-81BF-92B01EDBC450

Q37644850-85E57311-A4BE-4ED8-BC23-46FC4C813A28

Q37644850-86F545FA-9780-4973-8F78-350B0F6CFF0E

Q37644850-8D6C3BBE-62DD-42F9-B9F2-2737FB13BA52

Q37644850-8F73690B-4F96-4014-AD25-5754D65D2F7E

Q37644850-94E21E3C-0A30-48E1-9E1F-90FEBA59B1D4

Q37644850-97E64A19-FB76-41F3-8685-581FC5E97895

Q37644850-C9C42648-C6A8-4D63-9A5B-3400B42CF7A6

Q37644850-CABFB852-C450-40A3-98DB-FBE6F0F0DE13

P2860

Q37644850-03D912FA-DD9E-49D1-AE74-50361EC948A3

Q37644850-0D5A413F-2627-40D7-9CF8-367B3F4158B6

Q37644850-119C9FA7-411E-4384-BF6A-6BA824F96633

Q37644850-170E72B6-A257-4EA2-8DDE-FDBFB6508CF9

Q37644850-195D68AF-1670-49E3-9AA3-89DF39B38C86

Q37644850-1F4BDA06-9660-4C1B-B3F6-3DCC0A3216F0

Q37644850-2169B37E-2BE0-40DD-B342-AA2584B7A552

Q37644850-2F7629E7-2402-4950-A966-BD02579DFC3B

Q37644850-355541FB-D5BB-4BDB-9F01-3F559B317044

Q37644850-368AE42B-43AA-4639-88BF-308EE32FB2A3

P304

Q37644850-E110C79D-3A81-4720-BE98-75B20E9E4C25

P31

Q37644850-412FB1B6-422E-4FBB-BAF6-5D629F99AED6

P356

Q37644850-77B433C5-5571-488F-8622-D2FADAAC5BD7

P407

Q37644850-AB524D81-3DF7-4FAC-86A3-1CA17D1B5B14

P433

Q37644850-FB65C9F9-4F5D-44AD-90FD-FD8E81FBE534

P478

Q37644850-84804484-F1C0-46CA-A89E-938A480FDA43

P577

Q37644850-1ADCB131-8299-4F32-AB3B-55108CD604DA

P698

Q37644850-027933BA-74EE-4182-B4DC-D593C5F0009C

P921

Q37644850-94178042-02AC-41F0-8C89-810EEF262C4F

P932

Q37644850-2FC8C154-4742-4098-B1D5-B5F7331B2377

P356

ONCOTARGET.11043

P1433

P1476

FOXM1 confers resistance to ge ...... endent positive feedback loop.

@en

P2093

Erping Luo

http://www.w3.org/2001/XMLSchema#string

Huiling Yang

http://www.w3.org/2001/XMLSchema#string

Li Tian

http://www.w3.org/2001/XMLSchema#string

Li Wen

http://www.w3.org/2001/XMLSchema#string

Lisheng Zhao

http://www.w3.org/2001/XMLSchema#string

Mingling Wen

http://www.w3.org/2001/XMLSchema#string

Ning Wen

http://www.w3.org/2001/XMLSchema#string

Weiwei Zhang

http://www.w3.org/2001/XMLSchema#string

Wenchao Liu

http://www.w3.org/2001/XMLSchema#string

Xiaofei Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Cancer statistics, 2015

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Targeting the c-Met signaling pathway in cancer

Identification of nine tissue-specific transcription factors of the hepatocyte nuclear factor 3/forkhead DNA-binding-domain family

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

P304

59245-59259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11043

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27494877

http://www.w3.org/2001/XMLSchema#string

P921

P932

5312309

http://www.w3.org/2001/XMLSchema#string